Arquivamento - Art. 36 §1° da LPI
#11.2
09/23/2025
RPI 2855
Application data
Number
112019016705Type
Filing
Publication
PCT
US2018017813 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 09/23/2025. We update with every new RPI gazette, published weekly.
Applicants
INNOVATE BIOPHARMACEUTICALS, INC.
US
N. U. (pessoa física)
US
Inventors
A. B. (pessoa física)
US
J. M. (pessoa física)
US
IPC Classification
Priority claims
US
62/457.279 · 02/10/2017
Abstract
A presente invenção fornece métodos para tratar distúrbios associados com disfunção da barreira intestinal e permeabilidade intestinal elevada. A invenção envolve administrar uma quantidade eficaz de larazotida ou um derivado de larazotida a um sujeito ou um paciente em necessidade do mesmo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
09/23/2025
RPI 2855
#6.23
07/09/2024
RPI 2792
#15.35
10/19/2021
RPI 2650
#1.3
04/07/2020
RPI 2570
#1.1
08/27/2019
RPI 2538
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.